Overview
8-Bromo-3-methyl-3,7-dihydropurine-2,6-dione is a specialized brominated purine derivative with significant applications in pharmaceutical research and organic synthesis. Its structural features, including a methyl group at the 3-position and a bromine atom at the 8-position, make it a valuable intermediate in the development of nucleoside analogs and enzyme inhibitors. The compound is typically supplied as a white to off-white crystalline powder and requires careful handling due to its reactive nature. This compound is primarily utilized in academic and industrial research settings, where it serves as a building block for more complex molecules. Its role in medicinal chemistry is particularly notable, as it contributes to the synthesis of compounds with potential therapeutic effects. Researchers value its specificity and reactivity, which enable precise modifications in molecular design.
Physical and Chemical Properties
8-Bromo-3-methyl-3,7-dihydropurine-2,6-dione exhibits distinct physical and chemical properties that define its utility in research. The compound is a crystalline solid with a molecular weight of 229.03 g/mol and a melting point range of approximately 200-220°C, though it may decompose at higher temperatures. It is soluble in polar solvents like dimethyl sulfoxide (DMSO) but has limited solubility in water, which influences its handling and application in laboratory settings. The bromine substitution at the 8-position enhances its reactivity, making it a versatile intermediate for nucleophilic substitution reactions. The methyl group at the 3-position further modifies its electronic properties, contributing to its stability and interaction with biological targets. These characteristics are critical for its use in synthesizing analogs with tailored pharmacological activities.
Main Applications
The primary application of 8-Bromo-3-methyl-3,7-dihydropurine-2,6-dione lies in pharmaceutical research, where it serves as a key intermediate in the synthesis of nucleoside analogs. These analogs are often investigated for their potential as antiviral or anticancer agents, leveraging the compound's ability to mimic natural purines while introducing targeted modifications. Additionally, this compound is employed in the development of enzyme inhibitors, particularly those targeting purine-metabolizing enzymes. Its bromine atom provides a reactive site for further functionalization, enabling the creation of diverse derivatives with varied biological activities. Research laboratories and pharmaceutical companies commonly use it to explore new therapeutic pathways and optimize drug candidates.
Safety and Storage
Proper safety measures are essential when handling 8-Bromo-3-methyl-3,7-dihydropurine-2,6-dione due to its chemical reactivity. Laboratory personnel should wear appropriate protective equipment, including gloves, goggles, and lab coats, to prevent skin contact and inhalation. The compound should be used in a well-ventilated area or under a fume hood to minimize exposure to airborne particles. Storage conditions are equally critical to maintain the compound's stability. It should be kept in a cool, dry environment, protected from light and moisture, which could degrade its quality over time. Sealed containers with desiccants are recommended to prolong shelf life. Disposal should follow local regulations for brominated organic compounds to ensure environmental safety.
B2B Procurement Guide
When procuring 8-Bromo-3-methyl-3,7-dihydropurine-2,6-dione for B2B purposes, buyers should prioritize supplier reliability and product quality. Key considerations include verifying the compound's purity through certificates of analysis (CoA) and ensuring the supplier adheres to Good Manufacturing Practices (GMP). Purity levels of 95% or higher are typically required for research applications. Price ranges vary depending on the quantity and supplier, with bulk purchases often offering cost advantages. However, buyers should balance cost with quality, as impurities can affect experimental outcomes. Lead times and shipping conditions should also be confirmed, as some suppliers may require special handling to preserve the compound's integrity during transit.